{"slideshow_credits": null, "snippet": "So-called specialty drugs for diseases like rheumatoid arthritis have a narrow use and high costs, leaving the most vulnerable patients with huge bills.", "abstract": "Lawmakers in at least 20 states have introduced bills that would limit out-of-pocket payments by consumers for expensive drugs used to treat chronic diseases; bills aim to counter efforts by health plans to reduce the amount they pay for expensive medicines by making patients pay a percentage of the cost.", "section_name": "Health", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/04/13/health/states-seek-to-curb-exorbitant-drug-costs-incurred-by-patients.html", "lead_paragraph": "So-called specialty drugs for diseases like rheumatoid arthritis have a narrow use and high costs, leaving the most vulnerable patients with huge bills.", "headline": {"seo": "States Seek to Curb Exorbitant Drug Costs Incurred by Patients", "main": "States Seek Curb on Patient Bills for Costly Drugs", "print_headline": "States Seek Curb On Patient Bills For Costly Drugs"}, "_id": "53f5a43d38f0d87ef470e8c2", "word_count": "1249", "multimedia": [{"height": 350, "url": "images/2012/04/13/business/Copay1/Copay1-articleLarge.jpg", "legacy": {"xlarge": "images/2012/04/13/business/Copay1/Copay1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "350"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2012/04/13/business/Copay1/Copay1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/04/13/business/Copay1/Copay1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-04-13T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "States (US)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Health Insurance and Managed Care", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Law and Legislation", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Reform and Reorganization", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Pfizer Inc", "name": "organizations", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}